Akebia Therapeutics Inc. Shares Close in on 52-Week Low - Market Mover
The shares closed 0.9% above its 52-week low of $2.19, with trading volume lower than its 30 day average
Jan 10, 2022 by Kwhen Finance Editors
Akebia Therapeutics Inc. (AKBA) shares closed today at 0.9% above its 52 week low of $2.19, giving the company a market cap of $386M. The stock is currently down 2.2% year-to-date, down 28.7% over the past 12 months, and down 79.1% over the past five years. This week, the Dow Jones Industrial Average fell 0.3%, and the S&P 500 fell 1.9%.
Trading Activity
- Trading volume this week was 27.6% lower than the 20-day average.
- Beta, a measure of the stock’s volatility relative to the overall market stands at 1.5.
Technical Indicators
- The Relative Strength Index (RSI) on the stock was between 30 and 70.
- MACD, a trend-following momentum indicator, indicates a downward trend.
- The stock closed above its Bollinger band, indicating it may be overbought.
Market Comparative Performance
- The company's share price is the same as the S&P 500 Index , lags it on a 1-year basis, and lags it on a 5-year basis
- The company's share price is the same as the Dow Jones Industrial Average , lags it on a 1-year basis, and lags it on a 5-year basis
- The company share price is the same as the performance of its peers in the Health Care industry sector , lags it on a 1-year basis, and lags it on a 5 year basis
| Name | DoD %Δ | YTD %Δ | 1 Yr % | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|
| Akebia Therapeutics Inc. | -2.2 | -2.2 | -28.7 | -55.6 | 4.1 |
| Dow Jones Industrial Average | -0.0 | -0.3 | 18.5 | -2.0 | 23.2 |
| S&P 500 Index | -0.4 | -1.9 | 23.9 | -2.5 | 28.8 |
| Health Care | -0.7 | -5.2 | 13.2 | -5.5 | 21.4 |
Peer Group Comparative Performance
- The company's stock price performance year-to-date lags the peer average by 734.7%
- The company's stock price performance over the past 12 months lags the peer average by 462.3%
| Name | MKT CAP (USD) | P/E | YTD %Δ | 1 Yr %Δ | 52-Week H % | 52-Week L % |
|---|---|---|---|---|---|---|
| Akebia Therapeutics Inc. | AKBA | 0 | -2.2 | -28.7 | -55.6 | 4.1 |
| Peer Avg | N/A | 16.3 | -0.3 | -5.1 | -15.9 | 12.0 |
| Johnson & Johnson | JNJ | 25.6 | 1.7 | 11.4 | -3.5 | 15.4 |
| Novartis AG - ADR | NVS | 37.7 | 2.1 | -1.2 | -7.0 | 11.6 |
| AMGEN Inc. | AMGN | 22.8 | 1.0 | -1.7 | -16.7 | 12.5 |
| Nektar Therapeutics | NKTR | -4.7 | -6.1 | -34.0 | -52.3 | 20.4 |
This story was produced by the Kwhen Automated News Generator. For more articles like this, please visit us at finance.kwhen.com. Write to editors@kwhen.com. © 2021 Kwhen Inc.
Was this content valuable for you?
Tags: